GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Functional Technologies Corp (TSXV:FEB.H) » Definitions » EV-to-FCF

Functional Technologies (TSXV:FEB.H) EV-to-FCF : -0.07 (As of Sep. 21, 2024)


View and export this data going back to . Start your Free Trial

What is Functional Technologies EV-to-FCF?

EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, Functional Technologies's Enterprise Value is C$0.31 Mil. Functional Technologies's Free Cash Flow for the trailing twelve months (TTM) ended in Aug. 2012 was C$-4.40 Mil. Therefore, Functional Technologies's EV-to-FCF for today is -0.07.

The historical rank and industry rank for Functional Technologies's EV-to-FCF or its related term are showing as below:

TSXV:FEB.H's EV-to-FCF is not ranked *
in the Biotechnology industry.
Industry Median: 8.225
* Ranked among companies with meaningful EV-to-FCF only.

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2024-09-21), Functional Technologies's stock price is C$0.00. Functional Technologies's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Aug. 2012 was C$-0.260. Therefore, Functional Technologies's PE Ratio for today is At Loss.


Functional Technologies EV-to-FCF Historical Data

The historical data trend for Functional Technologies's EV-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Functional Technologies EV-to-FCF Chart

Functional Technologies Annual Data
Trend Aug03 Aug04 Aug05 Aug06 Aug07 Aug08 Aug09 Aug10 Aug11 Aug12
EV-to-FCF
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Functional Technologies Semi-Annual Data
Aug01 Aug02 Aug03 Aug04 Aug05 Aug06 Aug07 Aug08 Aug09 Aug10 Aug11 Aug12
EV-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Functional Technologies's EV-to-FCF

For the Biotechnology subindustry, Functional Technologies's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Functional Technologies's EV-to-FCF Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Functional Technologies's EV-to-FCF distribution charts can be found below:

* The bar in red indicates where Functional Technologies's EV-to-FCF falls into.



Functional Technologies EV-to-FCF Calculation

Functional Technologies's EV-to-FCF for today is calculated as:

EV-to-FCF=Enterprise Value (Today)/Free Cash Flow (TTM)
=0.307/-4.395
=-0.07

Functional Technologies's current Enterprise Value is C$0.31 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Functional Technologies's Free Cash Flow for the trailing twelve months (TTM) ended in Aug. 2012 was C$-4.40 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Functional Technologies  (TSXV:FEB.H) EV-to-FCF Explanation

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

Functional Technologies's PE Ratio for today is calculated as:

PE Ratio=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=0.00/-0.260
=At Loss

Functional Technologies's share price for today is C$0.00.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Functional Technologies's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Aug. 2012 was C$-0.260.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.


Functional Technologies EV-to-FCF Related Terms

Thank you for viewing the detailed overview of Functional Technologies's EV-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


Functional Technologies Business Description

Traded in Other Exchanges
N/A
Address
Functional Technologies Corp is incorporated under the corporate laws of British Columbia, Canada on October 18, 1999. The Company is a functional foods and biological health products company that is developing and commercializing advanced yeast products and other novel biological products for the food and health care industry. The company develops and commercializes proprietary, advanced yeast-based solutions to significant challenges in the food, beverage and healthcare industries, for which viable solutions are lacking. The Company's platform technologies improve the performance of innate yeast functions to primarily prevent the formation of naturally occurring toxins and contaminants that either affect final product quality or are classified by various global agencies as dangerous substances (e.g. carcinogens, neurotoxicants or reproductive toxicants). The Company operates in three geographic regions: Canada, Europe and the United States.

Functional Technologies Headlines

No Headlines